Last update July 16, 2022
Very Low Risk
Synthetic disaccharide (galactose and fructose) derivative of lactose used in the treatment of constipation. It is barely absorbed by the small intestine (AEMPS 2019, Sanis 2015, Würsch1989) and reaches the large intestine (colon) where it exerts its action as an osmotic laxative drug. The small amount that is absorbed is excreted unmodified in the urine. Oral administration.
At latest update were not found published data on excretion into breast milk. However, because it does not reach the mother's plasma, any concentration in the milk is not expected.
Medication with authorized indication in infants.
Several medical societies and expert authors consider the use of this medication safe during breastfeeding. (Gharehbaghi 2016, Mahadevan 2006, Müller 1995)
We do not have alternatives for 4-O-β-d-Galactopyranosyl-d-fructose since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM